<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05100147</url>
  </required_header>
  <id_info>
    <org_study_id>473</org_study_id>
    <nct_id>NCT05100147</nct_id>
  </id_info>
  <brief_title>Uterine Closure Techniques and Cesarean Scar Defect Risk</brief_title>
  <official_title>Comparison of Uterine Closure Techniques During Cesarean Section With Respect to the Development of Cesarean Scar Defects a Randomized Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mersin University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mersin University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cesarean operations are one of the most common obsetric operations and have an increasing&#xD;
      trend in all over the world. However unfortunately the operation techniques have not been&#xD;
      standardized yet. It is well known that different uterine closure techniques result in&#xD;
      differences with respect to wound healing on the uterus; however, the ideal uterine closure&#xD;
      technique is yet not known. The aim of this study is to assess the results of different&#xD;
      uterine closure techniques during cesarean section with respect to the development of&#xD;
      cesarean scar defects.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Scar thickness at postpartum 6th week</measure>
    <time_frame>Postpartum 6th weeks</time_frame>
    <description>The patients will be examined at the postpartum sixth week. During that visit uterine scar thickness will be measured by ultrasound. Measurement of uterine scar thickness will be performed perpendicular to the uterine wall and calipers will be placed on the serosal surface of the uterus and the delineation of the endometrium. These landmarks represent the inner and outer edge of the Cesarean scar.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Scar thickness at postpartum 6th month</measure>
    <time_frame>Postpartum 6th months</time_frame>
    <description>The patients will be reexamined at the postpartum sixth month. During that visit uterine scar thickness will be measured again. Measurement of uterine scar thickness will be performed with the same method (perpendicular to the uterine wall and calipers will be placed on the serosal surface of the uterus and the delineation of the endometrium. These landmarks represent the inner and outer edge of the Cesarean scar.)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Cesarean Section Complications</condition>
  <condition>Scar; Deformity</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The uterotomy suture technique is continous, double layer suturing, in which the first layer is continuous and unlocked involving all uterine layers and a second, continuous non-locking imbrictating layer is applied over the first suture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The uterotomy suture technique is continous, double layer suturing, in which the first layer is continuous and unlocked not including decidua and a second, continuous non-locking imbrictating layer is applied over the first suture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The uterotomy suture technique is continous ,double layer with the first layer unlocked, excluding the decidua and including the deep part of the myometrium, and the second layer unlocked including the remaining part of the myometrium.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Uterine closure during Cesarean section</intervention_name>
    <description>The uterotomy is sutured after the delivery of the fetus and the placenta with an appropriate delayed absorbable suture (number 1 polyglactin 910)</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. being nulliparous&#xD;
&#xD;
          2. having singleton fetus&#xD;
&#xD;
          3. not having diabetes and or hypertension&#xD;
&#xD;
          4. not having an intrauterine infection&#xD;
&#xD;
          5. body mass index &lt;35 kg/m2&#xD;
&#xD;
          6. not having any placental insertion anomalies&#xD;
&#xD;
          7. not having Mullerian anomalies&#xD;
&#xD;
          8. active phase of labor is not started.&#xD;
&#xD;
          9. no previous uterine surgeries&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. being multiparous&#xD;
&#xD;
          2. having multiple pregnancies&#xD;
&#xD;
          3. having diabetes and or hypertension&#xD;
&#xD;
          4. having an intrauterine infection&#xD;
&#xD;
          5. body mass index &gt;=35 kg/m2&#xD;
&#xD;
          6. having any placental insertion anomalies&#xD;
&#xD;
          7. having Mullerian anomalies&#xD;
&#xD;
          8. in active phase of labor&#xD;
&#xD;
          9. having previous uterine surgeries&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ezgi Oktay, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Mersin University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hakan Aytan, Prof.</last_name>
    <phone>+905056833866</phone>
    <email>drhakanaytan@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Meltem Nass Duce, Prof.</last_name>
    <phone>+903242410000</phone>
    <email>mnduce@mersin.edu.tr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mersin University Hospital</name>
      <address>
        <city>Mersin</city>
        <zip>33170</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meltem Nass Duce, Prof.</last_name>
      <phone>+903242410000</phone>
      <email>mnduce@mersin.edu.tr</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 15, 2021</study_first_submitted>
  <study_first_submitted_qc>October 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2021</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mersin University</investigator_affiliation>
    <investigator_full_name>Hakan Aytan</investigator_full_name>
    <investigator_title>Prof. Dr. Hakan Aytan</investigator_title>
  </responsible_party>
  <keyword>cesarean scar defect</keyword>
  <keyword>cesarean section</keyword>
  <keyword>uterine closure techniques</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

